drugset / Trial / NCT01505296

Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation

NCT01505296

RandomizedParallel-groupOpen-labelTreatment

Summary

The objective is to compare the progression of Atrial Fib (AF) burden by continuous monitoring in patients with recently diagnosed paroxysmal AF treated by catheter ablation (PVI) versus anti-arrhythmic drug (AAD) therapy.

Timeline

Start
2011-12
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dofetilide Small molecule
Subject flecainide Small molecule
Subject propafenone Unknown
Subject sotalol Small molecule

Indications